ClinicalTrials.govpublic full text
Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
end stage renal disease, chronic kidney disease, hyperphosphatemic, kidney disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885333
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.